Amazon's dietary supplement category operates under Amazon's own Dietary Supplement Selling Policies, which reference but are not identical to FDA requirements. Amazon uses automated claim detection, competitor flagging, and third-party enforcement requests to identify listings it considers non-compliant. The consequences range from listing suppression to account deactivation.
Amazon's Core Supplement Listing Requirements
Amazon requires that dietary supplement listings:
Not make disease claims (claims that the product diagnoses, treats, cures, or prevents a disease)
Not make drug claims (claims that imply the product functions as a drug)
Include the FDA disclaimer if making structure/function claims
Not reference specific diseases in product titles, bullet points, or descriptions
Not use drug names in supplement listings to imply equivalence
Have a Supplement Facts panel image uploaded to the listing
Comply with FTC substantiation requirements for any efficacy claims
Amazon's definition of a prohibited claim is broader than FDA's minimum standard in practice. Amazon has removed listings for claims that a stricter FDA analysis might have treated as permissible structure/function claims, because Amazon's automated systems flag disease-adjacent language without regulatory nuance.
Title Compliance on Amazon
Product titles are subject to the same claim restrictions as bullet points and descriptions. Common title violations that trigger Amazon enforcement:
Including disease names in titles ("for diabetes," "arthritis support," "anxiety relief")
Using "treats," "cures," "heals," or similar therapeutic language
Referencing drug names to imply equivalence ("natural [drug name] alternative")
Making specific outcome claims ("lowers cholesterol by 30%")
Amazon has also enforced against titles that use disease-related keywords even without explicit therapeutic language — "blood sugar" in a title in certain configurations, "thyroid support" formatted in certain ways, and "menopause relief" as a title term have all generated listing issues for brands.
Bullet Points and Description Compliance
Bullet points and A+ content descriptions must comply with the same rules as labels. The most common enforcement triggers:
"Anti-inflammatory" used without the required structure/function framing
"Reduces inflammation" without the "healthy inflammatory response" qualifier
Testimonials from users with named diseases ("I have arthritis and this helped")
Comparisons to prescription drugs
References to clinical conditions even as "supports people with [condition]"
Images and Infographics
Amazon's policy extends to images and infographics in the listing. Product images that display disease claims or show imagery strongly associated with disease states (people in medical settings, medical devices used to treat specific conditions) can trigger enforcement even if the text is compliant.
Amazon's Intellectual Property and Competitor Enforcement
Amazon allows competitors to file complaints against listings that make disease claims. Under Amazon's Brand Registry complaint system, a competitor can report a listing for drug/disease claim violations. Amazon typically takes action on such reports quickly, which creates an asymmetric enforcement risk: a well-run competitor can suppress your listing faster than FDA would ever move against your label.
What Happens When Amazon Acts
Listing suppression: The listing is removed from search results but the ASIN remains. The brand must submit a Plan of Action explaining the violation and the steps taken to remediate it.
Account suspension: Repeated violations or a single egregious violation can result in seller account suspension. Reinstatement requires a Plan of Action and may require submitting revised label images, certificates of analysis, or other documentation.
Staying Compliant on Amazon
The highest-risk areas for Amazon supplement compliance:
Disease mentions in titles (even as marketing shorthand)
"Anti-inflammatory" and "inflammation" language without proper structure/function framing
Drug comparisons in product copy
Testimonials mentioning diagnosed conditions in reviews or listing content
Missing FDA disclaimer on structure/function claims
Amazon compliance is faster-moving and less forgiving than FDA enforcement
Truli's product and marketing claim scanning covers Amazon listing content — titles, bullets, descriptions, and A+ content — flagging disease claim language, drug comparisons, and missing disclaimers before they generate competitor complaints or automated enforcement actions that can suppress listings and disrupt sales.
A note from Truli: Truli is not a law firm, and this article does not constitute or contain legal advice or create an attorney-client relationship. When determining your obligations and compliance with respect to relevant laws and regulations, you should consult a licensed attorney.
